Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
BPC-157 10mg $34.99 In stock BPC-157 10mg is a premium research peptide supplied as a lyophilized powder for laboratory and scientific investigations
In this collaborative study, co-led by Imperials Dr
Our compassionate, patient-centered approach ensures that your needs and concerns are heard and addressed with care
You may also like Product Description PT-141 Peptide | Buy PT-141 UK | Research Use Only PT-141 also known as Bremelanotide and Vyleesi (FDA-approved pharmaceutical formulation) is a synthetic cyclic heptapeptide (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, MW 1,025.2 Da) originally derived as an active metabolite of Melanotan II and engineered as a non-selective melanocortin receptor agonist with highest affinity for MC4R, acting centrally in the medial preoptic area and paraventricular nucleus of the hypothalamus to modulate dopaminergic, noradrenergic, and serotoninergic neurotransmission governing sexual desire and arousal making it the only CNS-acting melanocortin system research tool with a full Phase II and Phase III clinical evidence base, FDA approval (2019) as Vyleesi for hypoactive sexual desire disorder in premenopausal women, and a pharmacological profile mechanistically distinct from PDE5 inhibitors operating upstream on the neural circuitry of desire rather than downstream on vascular nitric oxide pathways
Moxifloxacins 8methoxy and 2fluoro substitutions boost Grampositive activity and reduce resistance development compared to older fluoroquinolones
US$ 20.57
US$ 23.96
US$ 26.42
US$ 21.89
